Showing results (221-230 of 284) with videos related to
Sort By:
Pageof 29
The American Journal of Medicine|March 19, 2013
Contemporary prevalence and correlates of incident heart failure with preserved ejection fractionJerry H Gurwitz, David J Magid, David H Smith, et al.American Journal of Alzheimer'S Disease and Other Dementias|September 10, 2016
Pilot Testing of the EIT-4-BPSD InterventionBarbara Resnick, Ann Kolanowski, Kimberly Van Haitsma, et al.Journal of General Internal Medicine|February 1, 2022
Presence of Geriatric Conditions Is Prognostic of Major Bleeding in Older Patients with Atrial Fibrillation: a Cohort StudyWeijia Wang, Jane S Saczynski, Darleen Lessard, et al.Pharmacoepidemiology and Drug Safety|August 8, 2013
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programsSengwee Toh, Jerry Avorn, Ralph B D'Agostino, et al.Journal of the American Geriatrics Society|January 30, 2019
AGS Report on Engagement Related to the NIH Inclusion Across the Lifespan PolicyCamille P Vaughan, William Dale, Heather G Allore, et al.The American Journal of Medicine|March 5, 2005
The incidence of adverse drug events in two large academic long-term care facilitiesJerry H Gurwitz, Terry S Field, James Judge, et al.Cancer|December 23, 2006
Racial differences in tumor stage and survival for colorectal cancer in an insured populationChyke A Doubeni, Terry S Field, Diana S M Buist, et al.Archives of Internal Medicine|September 15, 2005
Atypical antipsychotics and parkinsonismPaula A Rochon, Therese A Stukel, Kathy Sykora, et al.Circulation. Cardiovascular Quality and Outcomes|December 15, 2017
Change in Cognitive Function in the Month After Hospitalization for Acute Coronary Syndromes: Findings From TRACE-CORE (Transition, Risks, and Actions in Coronary Events-Center for Outcomes Research and Education)Jane S Saczynski, David D McManus, Molly E Waring, et al.Pharmacoepidemiology and Drug Safety|April 30, 2009
Cluster randomized trials to study the comparative effectiveness of therapeutics: stakeholders' concerns and recommendationsKathleen M Mazor, James E Sabin, Sarah L Goff, et al.Pageof 29